薬剤の配給監査支援システムの落とし穴
Erika Hayashi1, Takahiro Amemiya2, Takashi Tomita1,3,4
1Department of Pharmacy, Sanno Hospital, Minato-ku, JPN.
Cureus
|September 2, 2025
まとめ
配給する監査支援システムは,特に重い薬の場合は,誤った重量エラーの警告を発する可能性があります. これらのシステム上の問題への対処は,投与誤差を最小限に抑え,患者の安全性を向上させる上で極めて重要です.
科学分野:
- 薬局情報工学
- 臨床薬局の実践
- 医薬品安全システム
背景:
- 配給監査支援システムは,エラーを防ぐためにバーコードを使用して医薬品を認証します.
- これらのシステムは誤った警告を生じさせ,臨床使用を複雑にし,患者の安全に影響を与える可能性があります.
- 重量誤差の偽警告は,調査を必要とする特定のタイプの警報です.
研究 の 目的:
- C-correct II® 配給監査支援システムにおける誤った警告を重み付けやすい薬剤を特定する.
- 誤った警告に伴う 運用上の問題を解明するためです
- 自動配給システムの信頼性と安全性を高める.
主な方法:
- C-correct II®システムで誤った重量エラーの警告を誘発した研究薬.
- 偽警告を引き起こす薬の特徴と 偽警告を引き起こす薬の特徴を比較した.
- パターンを特定するために システムログと薬物データを分析した
主要な成果:
- C-correct II®システム内で誤った重量エラーが確認されました.
- 体重の誤差を引き起こす薬は,そのような誤差に関連していない薬よりも著しく重かった.
- システム不正確さに寄与する特定の薬物特性
結論:
- 重い薬はC-correct II®システムで誤った重量エラーを誘発する可能性が高い.
- 配給エラーを最小限に抑えるためには,これらの運用上の問題に対処することが不可欠です.
- 配給監査支援システムの改善は,医療の安全性を全体的に高めます.
さらに関連する動画
10:17High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry
Published on: April 23, 2019
9.8K
08:06Automated Acoustic Dispensing for the Serial Dilution of Peptide Agonists in Potency Determination Assays
Published on: November 10, 2016
7.7K
関連する概念動画
Pharmacovigilance
983
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
983
Drug Dosage Regimen: Overview
3.8K
A drug dosage regimen describes the specific instructions and schedule for administering a drug to a patient. It considers factors such as drug dosage, frequency, route of administration, and duration of treatment. Designing an appropriate dosage regimen for a patient aims to achieve a target drug concentration at the site of action.
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
3.8K
Drug Distribution: Volume of Distribution
5.9K
The volume of distribution refers to the theoretical volume necessary to contain the entire amount of an administered drug at the same concentration observed in the blood plasma. The body's intracellular fluid compartment, which makes up two-thirds of the total body water, is contrasted with the extracellular fluid compartment—comprising plasma and interstitial fluid—that accounts for one-third. The volume of distribution can vary depending on the characteristics of the drug.
5.9K
Drug Regulation
1.8K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.8K
Drug Control Governance: Regulatory Bodies and Their Impact
240
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
240
Drug Abuse and Addiction: Pharmacological Phenomena
655
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
655
